Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

US Patent 8193200 · Granted Jun 5, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for the treatment of body surface disorders2025
Cyclic amide-containing pyridyl xanthines as A2B antagonists2025
Treatment of cutaneous disorders2025
Adenosine A2A agonists for the treatment of cytokine storm syndrome2024
Applicator2024
Cyclic amide-containing pyridyl xanthines as A2B antagonists2023
Treatment of cutaneous disorders2021
Applicator2020
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017